CCL2 and breast cancer: It has been observed that in the mouse 4T1.2 mammary cancer model, pro-inflammatory monocytes with MDSCs features (IL4R, CD49b, CD62L, CD11b) can be recruited by the chemokine CCL2 in the pre-metastatic lungs where they foster metastasis.